Search | Clinical Trials Finder

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:56 PM EDT

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1849–1872 of 2,873 matching trials from the local directory fallback.

Filters: Intervention: SC Clear all

Conditions: Acute Kidney Injury, Anesthesia, Surgery Complications
Interventions: EHR-Embedded AKI Risk Score, EHR-Embedded AKI Risk Score with Best Practice Advisory; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 25,518 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Care Transition, Medication Adherence, Medication Discrepancy, Type 2 Diabetes
Interventions: MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2029 – 2031
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: BRCA1-Related Hereditary Breast and Ovarian Cancer Syndrome, BRCA2-Related Hereditary Breast and Ovarian Cancer Syndrome, Hereditary Neoplastic Syndrome, Lynch Syndrome
Interventions: Discussion, Internet-Based Intervention, Survey Administration, Telephone-Based Intervention; Other · Behavioral
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Complicated Parapneumonic Effusion, Empyema, Pleural
Interventions: Intrapleural Saline with possible escalation to intraplerual alteplase and dornase.; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Hanover, New Hampshire

Conditions: Food Insecurity, Type 1 Diabetes (T1D)
Interventions: Medically tailored meal kits, Nutrition Coaching, Produce prescription; Behavioral
Lead sponsor: Katelyn Fox; Other
Eligibility: 5 Years to 12 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Advanced Hormone Receptor-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Hormone Receptor-Positive Breast Carcinoma, Unresectable Hormone Receptor-Positive Breast Carcinoma
Interventions: Biopsy Procedure, Biospecimen Collection, Bone Scan, Computed Tomography, Electronic Health Record Review, Magnetic Resonance Imaging, Positron Emission Tomography, Treatment Planning, Treatment Regimen; Procedure · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Duarte, California • Irvine, California

Conditions: Idiopathic Scoliosis
Interventions: Scoliosis Correction System; Device
Lead sponsor: Globus Medical Inc; Industry
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Batten Disease, Batten's Disease, CLN6, Neuronal Ceroid Lipofuscinosis, Neuronal Ceroid Lipofuscinosis CLN6
Interventions: scAAV9.CB.CLN6 (dose: 1.5E14 vector genomes); Drug
Lead sponsor: The Charlotte and Gwenyth Gray Foundation; Other
Eligibility: 4 Months and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8
Interventions: Biospecimen Collection, Bone Scan, C. butyricum CBM 588 Probiotic Strain Capsule Formulation MO-03, Computed Tomography, Zanzalintinib; Procedure · Drug
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Critical Illness, ICU Acquired Weakness, Sarcopenia
Interventions: MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES); Combination Product
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 60 Years to 99 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Preventive Health Services (PREV HEALTH SERV)
Interventions: PIVOT-IN, Standardized Vaccine Eligibility Screening; Behavioral · Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: Not listed
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: HIV, Substance Use Disorder (SUD)
Interventions: Social network intervention, Substance use disorder screening; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Male only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Barrett's Esophagus
Interventions: Screening Reminder; Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Sickle Cell, Sickle Cell Anemia (HbSS), Sickle Cell Anemia in Children, Sickle Cell Disease, Sickle Cell Disease (SCD)
Interventions: Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session; Behavioral · Other
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: HIV (Human Immunodeficiency Virus), Hepatitis C Virus (HCV), Hepatitis C Virus (HCV) Infection
Interventions: FOCUS (Universal Screening), HepC-EnD (Targeted Screening), Physician-Initiated Screening (Conventional Screening); Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 79 Years
Enrollment: 6,466 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Hepatic Encephalopathy, Liver Cirrhosis, Portal Shunt Systemic
Interventions: Endoscopic ultrasound-guided transgastric embolization of the spontaneous portosystemic shunts, Interventional Radiology for shunt embolization/retrograde tranvenous obliteration; Procedure
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Dyslipidemia, Hypertension, Obesity & Overweight
Interventions: Nutrition education and produce prescription card; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 2 Years to 17 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Tourette Syndrome
Interventions: Placebo, SCI-110; Other · Drug
Lead sponsor: Neurothera Labs Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Fibromyalgia
Interventions: Auricular transcutaneous electrical nerve stimulation device; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Posttraumatic Stress Disorder (PTSD)
Interventions: Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation Sham; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Prostate Cancer
Interventions: Nonlinear Microscope (NLM); Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Liver Diseases, Liver Transplant; Complications
Interventions: Autologous adipose derived mesenchymal stromal cells (AMSC); Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Health, Health Promotion
Interventions: Kūkākūkā Discussion Sessions; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older · Male only
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Brain Injury, Cardiac Surgery Requiring Cardiopulmonary Bypass, Congenital Heart Defect
Interventions: Collecting discarded blood samples; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Up to 18 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Real-Time Acute Kidney Injury Perioperative Prediction Clinical Trial

MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients

A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families

Flush, Lyse, Operate

Pilot of Food Is Medicine Interventions to Reduce Cardiovascular Disease Risk in Children With Food Insecurity and Diabetes

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis

Gene Therapy Trial for CLN6 Batten Disease

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors

A Vaccine Communication Training Intervention for Pediatric Inpatient Clinicians

Combining Social Network Strategies and Routine Substance Use Screening

Enhancing Screening Practices for BE

Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease

Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System

Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy

Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth

SCI-110 in the Treatment of Tourette Syndrome

taVNS Treatment for Fibromyalgia

Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) for Treatment of Post-Traumatic Stress Disorder (PTSD)

PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy

Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications

The Ku Ola Project: Enhancing Health Promotion Among Native Hawaiian Men.

The Association Between Tau & GFAP and Postoperative Neurological Impairment in Patients Undergoing Cardiac Surgery